Question 460
An international research rollout receives a regulatory change midway through validation and the team assumes its existing approval covers the new rule. The team has identified a response and must obtain a justified decision before moving forward. Which next decision BEST preserves the agreed business outcome?
Explanation
Correct Answer
This decision respects the accountable project authority and the scenario’s remaining exposure: Obtain the authorized regulator or compliance interpretation before the irreversible next trial stage. The response being governed is Assess applicability, update the compliance register, and map changed obligations to validation and approvals. and the completion measure is A documented gap assessment shows responsible owners and evidence satisfying the new effective requirements.
Incorrect Answers
Seek an investment go/no-go decision if forecast benefit no longer justifies the planned scope. That safeguard does not address the specific risk here: a previous approval does not necessarily authorize implementation under a changed binding rule. The relevant follow-up is: Obtain the authorized regulator or compliance interpretation before the irreversible next trial stage.
Reserve capacity for verified systemic improvement when repeated defects exceed the risk tolerance. That safeguard does not address the specific risk here: a previous approval does not necessarily authorize implementation under a changed binding rule. The relevant follow-up is: Obtain the authorized regulator or compliance interpretation before the irreversible next trial stage.
Require the information owner to approve a lawful revised data strategy or remove the restricted inputs. That safeguard does not address the specific risk here: a previous approval does not necessarily authorize implementation under a changed binding rule. The relevant follow-up is: Obtain the authorized regulator or compliance interpretation before the irreversible next trial stage.